A counterintuitive antibody cocktail disrupts coxsackievirus

Zost, Seth J.; Vogt, Matthew R.

doi:10.1016/j.chom.2022.08.010

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One approach to limit the risk of antibody resistance and provide broad synergetic neutralizing capability is to use antibody combinations to target different viral conserved epitopes ( Crowe 2022 , Zost and Vogt 2022 ). Typically, antibody cocktail rational design tends to select non-competing nAbs ( Crowe 2022 , Carter and Rajpal 2022 ).…”

Section: Discussionmentioning

confidence: 99%

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

et al. 2023

View full text Add to dashboard Cite

Continual evolution of the SARS-CoV-2 virus has allowed for its gradual evasion of neutralizing antibodies (nAbs) produced in response to natural infection or vaccination. The rapid nature of these changes has incited a need for the development of superior broad nAbs and/or the rational design of an antibody cocktail that can protect against the mutated virus strain. Here, we report two ACE2 competing nAbs—8H12 and 3E2—with synergistic neutralization but evaded by some Omicron subvariants. Cryo-EM reveals the two nAbs synergistic neutralizing virus through a rigorous pairing permitted by rearrangement of the 472-489 loop in the RBD to avoid steric clashing. Bispecific antibodies based on these two nAbs tremendously extend the neutralizing breadth and restore neutralization against recent variants including currently dominant XBB.1.5. Together, these findings expand our understanding of the potential strategies for the neutralization of SARS-CoV-2 variants toward the design of broad-acting antibody therapeutics and vaccines.

show abstract